TWA
SCLN

TCI Wealth Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

TCI Wealth Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-118
Closed -$1K – 1477
2017
Q3 		$1K Hold
118
– – ﹤0.01% 1303
2017
Q2 		$1K Hold
118
– – ﹤0.01% 1312
2017
Q1 		$1K Hold
118
– – ﹤0.01% 1257
2016
Q4 		$1K Hold
118
– – ﹤0.01% 1317
2016
Q3 		$1K Hold
118
– – ﹤0.01% 1317
2016
Q2 		$2K Hold
118
– – ﹤0.01% 998
2016
Q1 		$1K Buy
+118
New +$1.05K ﹤0.01% 1253

TCI Wealth Advisors's SCLN Position: Q4 2017 in Review

TCI Wealth Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 118 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in SCLN in Q1 2016 and held it in 7 quarters. The position peaked at $2K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • TCI Wealth Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • TCI Wealth Advisors sold 118 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q1 2016 and held it in 7 quarters.
  • TCI Wealth Advisors's Sciclone Pharmaceuticals Inc position peaked at $2K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on TCI Wealth Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.